• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过重组大肠杆菌的高密度培养和基于温度的复性方法,实现核心链霉亲和素生产的过程强化。

Process intensification of core streptavidin production through high-cell-density cultivation of recombinant E. coli and a temperature-based refolding method.

机构信息

Institute for Research in Molecular Medicine, Universiti Sains Malaysia, Minden, 11800, Penang, Malaysia.

Usains Biomics Laboratory Testing Services Sdn. Bhd., Universiti Sains Malaysia, Minden, 11800, Penang, Malaysia.

出版信息

J Biotechnol. 2018 Jun 20;276-277:34-41. doi: 10.1016/j.jbiotec.2018.04.012. Epub 2018 Apr 19.

DOI:10.1016/j.jbiotec.2018.04.012
PMID:29679607
Abstract

An intensified process was developed that enables high level production of recombinant core streptavidin (cSAV), a non-glycosylated tetrameric protein utilised in a wide range of applications. A pH-stat fed-batch feeding strategy was employed to achieve high-cell-density and improve volumetric yield of cSAV which was expressed as inclusion bodies (IBs). The effect of induction at different cell densities (OD 20, 60 and 100) on volumetric and specific yield were then studied. Highest volumetric yield of cSAV (1550 mg L) was obtained from induction at OD 100 without significant reductions in specific yield. To recover active cSAV from IBs, the possibility of refolding using a temperature-based refolding method was investigated. Refolded cSAV obtained from temperature-based refolding were then compared against cSAV refolded with conventional dialysis and dilution methods using quantitative and qualitative metrics. The temperature-based refolding method was found to improve the yield of cSAV by 6-18% in comparison to conventional methods without compromising quality. Intensification was achieved by reductions in process volumes and a more concentrated product stream. Using the newly developed process, the volumetric yield of cSAV IBs was improved by thirty-six fold in comparison to low-cell-density shake flask cultivation, and 33% of cSAV can be recovered from IBs at 90% purity.

摘要

开发了一种强化工艺,能够实现高产量的重组核心链霉亲和素(cSAV),这是一种非糖基化的四聚体蛋白,广泛应用于各种应用中。采用 pH -stat 补料分批培养策略来实现高密度细胞和提高 cSAV 的比产量,cSAV 以包涵体(IB)的形式表达。然后研究了在不同细胞密度(OD 20、60 和 100)下诱导对比产量和比产率的影响。在 OD 100 下诱导时,cSAV 的比产量最高(1550mg/L),而比产率没有明显降低。为了从 IB 中回收活性 cSAV,研究了使用基于温度的复性方法进行复性的可能性。然后使用定量和定性指标比较了基于温度的复性方法与传统透析和稀释方法复性的 cSAV。结果发现,与传统方法相比,基于温度的复性方法可以提高 cSAV 的产量 6-18%,而不影响质量。通过减少工艺体积和更浓缩的产物流来实现强化。使用新开发的工艺,与低细胞密度摇瓶培养相比,cSAV 的包涵体比产量提高了三十六倍,并且可以从 IB 中以 90%的纯度回收 33%的 cSAV。

相似文献

1
Process intensification of core streptavidin production through high-cell-density cultivation of recombinant E. coli and a temperature-based refolding method.通过重组大肠杆菌的高密度培养和基于温度的复性方法,实现核心链霉亲和素生产的过程强化。
J Biotechnol. 2018 Jun 20;276-277:34-41. doi: 10.1016/j.jbiotec.2018.04.012. Epub 2018 Apr 19.
2
Removal and monitoring of residual nucleic acids from core streptavidin inclusion bodies for increased refolding yield.从核心链霉亲和素包涵体中去除和监测残留核酸以提高复性产率。
Protein Expr Purif. 2025 Jan;225:106591. doi: 10.1016/j.pep.2024.106591. Epub 2024 Aug 22.
3
Intensification of Inclusion Body Processing via Temperature-Based Refolding.通过基于温度的重折叠强化包涵体处理
Methods Mol Biol. 2023;2617:189-200. doi: 10.1007/978-1-0716-2930-7_13.
4
Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli.从大肠杆菌包涵体中进行治疗性蛋白质的生物加工。
Adv Biochem Eng Biotechnol. 2003;85:43-93. doi: 10.1007/3-540-36466-8_3.
5
Dialysis strategies for protein refolding: preparative streptavidin production.
Protein Expr Purif. 2003 Sep;31(1):149-54. doi: 10.1016/s1046-5928(03)00133-5.
6
High-level expression and efficient refolding of therapeutically important recombinant human Interleukin-3 (hIL-3) in E. coli.治疗性重要重组人白细胞介素-3(hIL-3)在大肠杆菌中的高水平表达与高效重折叠
Protein Expr Purif. 2017 Mar;131:51-59. doi: 10.1016/j.pep.2016.11.005. Epub 2016 Nov 15.
7
Refolding and purification of cGMP-grade recombinant human neurturin from Escherichia coli inclusion bodies.从大肠杆菌包涵体中复性和纯化 cGMP 级别的重组人神经生长因子。
Protein Expr Purif. 2020 Apr;168:105552. doi: 10.1016/j.pep.2019.105552. Epub 2019 Dec 19.
8
Enhancing the Yield of Active Recombinant Chitobiase by Physico-Chemical and In Vitro Refolding Studies.通过物理化学和体外重折叠研究提高活性重组壳二糖酶的产量
Protein J. 2016 Feb;35(1):72-9. doi: 10.1007/s10930-016-9648-z.
9
A comparative approach to recombinantly produce the plant enzyme horseradish peroxidase in Escherichia coli.一种在大肠杆菌中重组生产植物酶辣根过氧化物酶的比较方法。
J Biotechnol. 2017 Apr 20;248:15-24. doi: 10.1016/j.jbiotec.2017.03.003. Epub 2017 Mar 11.
10
[High-cell density cultivation of recombinant Escherichia coli for production of TRAIL by using a 2-stage feeding strategy].[采用两阶段补料策略进行重组大肠杆菌的高密度培养以生产肿瘤坏死因子相关凋亡诱导配体(TRAIL)]
Sheng Wu Gong Cheng Xue Bao. 2004 May;20(3):408-13.

引用本文的文献

1
Optimization of the Production of Vaccine Epitopes from Alpha-Toxin Using Strains of Recombinant .利用重组菌株优化α毒素疫苗表位的生产
Microorganisms. 2025 Jun 26;13(7):1481. doi: 10.3390/microorganisms13071481.
2
Design of ancestral mammalian alkaline phosphatase bearing high stability and productivity.具有高稳定性和高产量的原始哺乳动物碱性磷酸酶的设计
Appl Environ Microbiol. 2024 Dec 18;90(12):e0183124. doi: 10.1128/aem.01831-24. Epub 2024 Nov 15.
3
A combination fermentation strategy for simultaneously increasing cellular NADP(H) level, biomass, and enzymatic activity of glufosinate dehydrogenase in Escherichia coli.
一种组合发酵策略,可同时提高大肠杆菌中细胞 NADP(H)水平、生物量和草铵膦脱氢酶的酶活。
Bioprocess Biosyst Eng. 2023 Jun;46(6):867-878. doi: 10.1007/s00449-023-02871-8. Epub 2023 Apr 6.
4
Mirror-image streptavidin with specific binding to L-biotin, the unnatural enantiomer.具有特异结合 L-生物素(非天然对映体)能力的镜像链霉亲和素。
Sci Rep. 2022 Jun 10;12(1):9568. doi: 10.1038/s41598-022-13763-4.
5
Development of Processes for Recombinant L-Asparaginase II Production by Bl21 (De3): From Shaker to Bioreactors.利用BL21(DE3)生产重组L-天冬酰胺酶II的工艺开发:从摇瓶到生物反应器
Pharmaceutics. 2020 Dec 24;13(1):14. doi: 10.3390/pharmaceutics13010014.